Optima Health (OPT): PAM Healthcare acquisition
This situation live
OPT Optima Health
16 Feb 2026 · Agreement signed 14 Feb; awaiting Irish FDI clearance · −11% until the next step
Completion of the Acquisition is only conditional on clearance being obtained from the Irish Foreign Direct Investment regime
23 Mar 2026 · Signed; awaiting completion; CFO handover planned · +0% until the next step
Subject to the successful completion of the recently announced acquisition of PAM Healthcare, Optima will appoint Andrew Bones as Interim Chief Financial Officer.
24 Mar 2026 · Unconditional; completion expected on or around 26 March · −1% until the next step
As a result, the Acquisition is now unconditional and is expected to complete on or around 26 March 2026 ("Completion").
31 Mar 2026 · Completed 26 March; open offer launched to repay bridge · +6% until the next step
The Acquisition completed on 26 March 2026.
17 Apr 2026 · Completed 26 March; open offer pending · +2% until the next step
The recent acquisition of PAM, which completed on 26 March 2026, positions the enlarged Group to capitalise on the growing market opportunity, whilst benefiting from significant operational and cost s
16 Jun 2026 · Completed and funded; integration under way · +24% until the next step
Integration activity is well underway with annualised synergies of £1.3 million already delivered as of 1 June 2026
17 Aug 2026 · Completed and funded; integration under way · +2% since
Integration of PAM progressing to plan, with £2.1 million of annualised cost synergies delivered or in the process of being delivered as at 31 July 2026, against a medium-term target of £5 million
PAM Healthcare acquisition
Completed and funded; integration under way
Next: deliver remaining synergies towards £5m target
Every step · 7
- 16 Feb 2026 Agreement signed 14 Feb; awaiting Irish FDI clearance – Completion of the Acquisition is only conditional on clearance being obtained from the Irish Foreign Direct Investment regime ↗
- 23 Mar 2026 Signed; awaiting completion; CFO handover planned – Subject to the successful completion of the recently announced acquisition of PAM Healthcare, Optima will appoint Andrew Bones as Interim Chief Financial Officer. ↗
- 24 Mar 2026 Unconditional; completion expected on or around 26 March – As a result, the Acquisition is now unconditional and is expected to complete on or around 26 March 2026 ("Completion"). ↗
- 31 Mar 2026 Completed 26 March; open offer launched to repay bridge – The Acquisition completed on 26 March 2026. ↗
- 17 Apr 2026 Completed 26 March; open offer pending – The recent acquisition of PAM, which completed on 26 March 2026, positions the enlarged Group to capitalise on the growing market opportunity, whilst... ↗
- 16 Jun 2026 Completed and funded; integration under way – Integration activity is well underway with annualised synergies of £1.3 million already delivered as of 1 June 2026 ↗
- 17 Aug 2026 Completed and funded; integration under way – Integration of PAM progressing to plan, with £2.1 million of annualised cost synergies delivered or in the process of being delivered as at 31 July 2026,... ↗
What is happening
Optima Health: PAM Healthcare acquisition – Completed and funded; integration under way. ['Completed and funded; integration under way']
- In short
- Optima signed the c.£100m cash PAM deal on 16 February 2026 and completed it on 26 March, funded by bank debt and a £30m bridge. The underwritten open offer (24 April) repaid the bridge. The audited FY26 results show net debt of £94.4m at 31 March and synergies delivered or in progress rising to £2.1m by 31 July, from £1.3m by 1 June.
- Announced
- 16 Feb 2026 · Agreement signed 14 Feb; awaiting Irish FDI clearance
- Latest
- 17 Aug 2026 · Completed and funded; integration under way
- Underwriter
- Deacon Street (Lord Ashcroft) underwrites up to £35m; LA Concert Party could reach up to 40.56% of voting rights
- Synergies
- £2.1m annualised cost synergies delivered or in progress at 31 July 2026; £5m medium-term target
- Medium-term targets
- £200m revenue and £40m adjusted EBITDA, which PAM synergies should help reach
- Price
- c.£100m total consideration; completed 26 March 2026
- Funding
- Bank debt plus £30m bridge, repaid from c.£35.0m gross open offer proceeds
- Net debt
- £94.4m excluding leases at 31 March 2026, including the £30m bridge
- PAM result
- Unaudited 2025 revenue £66.6m, adjusted EBITDA £8.2m
- Targets
- Medium-term £200m revenue and £40m adjusted EBITDA (20% margin)
What comes next
deliver remaining synergies towards £5m target.
From the company's own announcements. Not investment advice.
Briefing Pro
New to Optima Health? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the OPT briefing →Also at Optima Health 4 open
Transformational contract / build-outUK Armed Forces contract mobilisation – Mobilisation progressing to plan
Stake building towards controlMichael Anthony Ashcroft towards control – 27.59% (from 24%)
Transformational contract / build-outPerkbox EAP partnership – Contract signed, implementation starting
Turnaround plan with targetsPlatform enhancement programme – Programme commenced, delivery under way
Insider conviction4 directors buying – £136k in 7 buys · closed
Optima Health – company page →